CM/TNS/24/5711 -NHS Framework for the supply of Ustekinumab
key details
| Value | £230,000,000 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | East Midlands, East of England, London, North East, North West, South East, South West, West Midlands, Yorkshire and the Humber |
| Deadline | 1 Jul 2024 |
| Contract start | 1 Sept 2024 |
| Contract end | 31 Aug 2026 |
| Procedure | open |
| SME suitable | Yes |
| OCID | ocds-b5fd17-bd18e8bf-f1dd-455f-8b23-688c3cad9f30 |
Awards (6)
This procurement was awarded to 6 suppliers. Values shown are per-award; the notice total is £230,000,000.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord-UK Ltd shared | £230,000,000 | 12 Aug 2024 | active |
| Amgen Ltd shared | £230,000,000 | 12 Aug 2024 | active |
| Celltrion Healthcare United Kingdom Limited shared | £230,000,000 | 12 Aug 2024 | active |
| Janssen-Cilag Ltd shared | £230,000,000 | 12 Aug 2024 | active |
| Sandoz Ltd shared | £230,000,000 | 12 Aug 2024 | active |
| Thornton and Ross Ltd shared | £230,000,000 | 12 Aug 2024 | active |
description
Project title: NHS National Framework for the supply of Ustekinumab 1 September 2024
Offer reference number: CM/TNS/24/5711
CM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & South of England. Period of framework: 1 September 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
CM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North of England and Midlands & East. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 12 Sept 2024 | Award (award) | · | 3f298bc7-1d5a-48e1-8190-a3aac0caff4e-785062 |
more from NHS England
- Urgent Award - haematological screening · £16,202 · 29 Jul 2026
- HSCN-AWS Connectivity Service for Spine · £228,060 · 29 Jul 2026
- Incentive Voucher Provider · £60,000 · 29 Jul 2026
- CRM for NHSE participant/candidate data 26-27 · £56,640 · 28 Jul 2026
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.